SIRVARD KAPTRYAN: Open Payments
NPI 1841727658 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,785 in 154 payments from 18 companies in 2025. Trend: 2023 $2,166 · 2024 $2,597 · 2025 $2,785
Food & beverage: $2,785
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 48 | $653 |
| Amgen Inc. | 23 | $413 |
| UCB, Inc. | 12 | $282 |
| GlaxoSmithKline, LLC. | 14 | $249 |
| Janssen Biotech, Inc. | 11 | $242 |
| Novartis Pharmaceuticals Corporation | 10 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $142 |
| Lilly USA, LLC | 9 | $128 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $102 |
| Aurinia Pharma U.S., Inc. | 4 | $82 |
Products named: RINVOQ, SKYRIZI, Bimzelx, TREMFYA, BENLYSTA, TAVNEOS, Otezla, TALTZ.
Industry payments across CA — which companies pay providers there.
